We have a suspicion that you are an automated web bot software, not a real user. To keep our site fast for other users, we have slowed down this page. The slowdown will gradually disappear. If you think this is a mistake, please contact us at genome-www@soe.ucsc.edu. Also note that all data for hgGeneGraph can be obtained through our public MySQL server and all our software source code is available and can be installed locally onto your own computer. If you are unsure how to use these resources, do not hesitate to contact us.
UCSC Genome Browser Gene Interaction Graph
Gene interactions and pathways from curated databases and text-mining

◀ Back to CD4

CD4 — GP5

Text-mined interactions from Literome

Yachou et al., Biochem Biophys Res Commun 1999 : Binding of soluble recombinant HIV envelope glycoprotein , rgp120, induces conformational changes in the cellular membrane anchored CD4 molecule
Basmaciogullari et al., J Virol 2002 : Binding of the HIV-1 gp120 envelope glycoprotein to the chemokine receptors normally requires prior interaction with CD4
Gorse et al., Clinical and vaccine immunology : CVI 2006 (HIV Infections) : Mean frequencies of HIV-1 envelope glycoprotein stimulated , activated intra-cellular IFN-gamma producing CD4 ( + ) and CD8 ( + ) lymphocytes and of interleukin-2 producing CD4 ( + ) lymphocytes did not increase after vaccination, but cytokine producing cells were detectable in some patients
Rawat et al., Mol Membr Biol 2008 : These engineered cells are resistant to fusion mediated CD4 dependent HIV-1 envelope glycoprotein
Hu et al., J Immunol 2008 (HIV Infections) : We previously demonstrated that HIV envelope glycoprotein ( Env ), delivered in the form of a vaccine and expressed by dendritic cells or 293T cells, could suppress Ag-stimulated CD4 ( + ) T cell proliferation
Azevedo-Pereira et al., Acta Med Port 2008 (HIV Infections) : Binding of SU glycoprotein to CD4 molecule , enables HIV to adsorb to target cell membrane and also initiates conformational changes in SU glycoprotein that enable it to bind to a second receptor ( coreceptor )
Kassa et al., J Virol 2009 : Binding to the primary receptor CD4 induces conformational changes in the human immunodeficiency virus type 1 ( HIV-1 ) gp120 envelope glycoprotein that allow binding to the coreceptor ( CCR5 or CXCR4 ) and ultimately trigger viral membrane-cell membrane fusion mediated by the gp41 transmembrane envelope glycoprotein
Andersen et al., Scand J Immunol 1991 : Conglutinin binds the HIV-1 envelope glycoprotein gp 160 and inhibits its interaction with cell membrane CD4
Juszczak et al., J Biol Chem 1991 : Effect of human immunodeficiency virus gp120 glycoprotein on the association of the protein tyrosine kinase p56lck with CD4 in human T lymphocytes
Lay et al., J Biol Chem 2011 : The binding by HIV-1 gp120 to CD4 and a chemokine receptor activates the membrane fusion glycoprotein , gp41
Demaria et al., AIDS Res Hum Retroviruses 1996 : Soluble CD4 induces the binding of human immunodeficiency virus type 1 to cells via the V3 loop of glycoprotein 120 and specific sites in glycoprotein 41
Martin et al., Science 1997 : The gp120 envelope glycoprotein from human immunodeficiency virus strain HIV-1 ( YU2 ) bound human CCR5 ( CCR5hu ) or rhesus macaque CCR5 ( CCR5rh ) only in the presence of CD4
Sullivan et al., J Virol 1998 : CD4 Induced conformational changes in the human immunodeficiency virus type 1 gp120 glycoprotein : consequences for virus entry and neutralization
Wang et al., J Biol Chem 1998 : The interaction of human immunodeficiency virus type 1 ( HIV-1 ) with CD4 and one of a cadre of chemokine receptors triggers conformational changes in the HIV-1 envelope ( Env ) glycoprotein that lead to membrane fusion
Sullivan et al., J Virol 1998 : Determinants of human immunodeficiency virus type 1 envelope glycoprotein activation by soluble CD4 and monoclonal antibodies
Puri et al., Proc Natl Acad Sci U S A 1998 : The neutral glycosphingolipid globotriaosylceramide promotes fusion mediated by a CD4 dependent CXCR4 utilizing HIV type 1 envelope glycoprotein
Mavoungou et al., J Med Primatol 1998 (Monkey Diseases...) : Our results demonstrate that the soluble viral glycoprotein induce a specific phospholipase A2 (PLA2) activation in lymphocytes through CD4